Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KRAS - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KRAS - Cyclin-dependent kinase inhibitor R547 effect on peripheral blood mononuclear cells: dose response and time course
KRAS - Hepatocyte growth factor treatment of prostate cancer DU145 cell line: time course
APC - Recurrent and non-recurrent prostate cancer primary tumors
KRAS - Saliva of pre-treatment pancreatic cancer patients
KRAS - Lymphatic endothelial cell response to Prox1 and NR2F2 depletion
APC - ERalpha-negative ERbeta-positive breast carcinoma response to tamoxifen
TP53 - Keratinocyte response to GLI1 and GLI2 induction: time course
TP53 - Hydrostatic pressure-responsive genes in optic nerve head astrocytes
TP53 - Sotrastaurin effect on mantle cell lymphoma cell lines
KRAS - Human epidermal growth factor receptor 2-positive breast cancer brain metastases
GEO DataSets Gene Chromosome neighbors Homologene neighbors
APC - NeOAdjuvant Herceptin (NOAH) trial: formalin-fixed, paraffin-embedded breast cancer biopsies
TP53 - SW480 KRAS-mutant colorectal cancer cell line response to dual inhibition of tankyrase and MEK: time course
TP53 - Newly diagnosed and chronic pediatric immune thrombocytopenia: peripheral blood T-cells
KRAS - Tibial muscular dystrophy
KRAS - Colon cancer cell lines with acquired resistance to BRAF inhibitor
KRAS - Transcription factor OTX2 oncogene silencing effect on D425 medulloblastoma cell line: time course
KRAS - Unresectable colorectal cancer primary or metastatic lesions: training set
KRAS - Gamma secretase inhibitor MRK-003 effect on pancreatic ductal adenocarcinoma tumor xenografts
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on